Lytic Polysaccharide Monooxygenases (LPMOs) constitute an enigmatic class of enzymes, the discovery of which has opened up a new arena of riveting research. LPMOs can oxidatively cleave the glycosidic bonds found in carbohydrate polymers enabling the depolymerization of recalcitrant biomasses, such as cellulose or chitin. While most studies have so far mainly explored the role of LPMOs in a (plant) biomass conversion context, alternative roles and paradigms begin to emerge. In the present review, we propose a historical perspective of LPMO research providing a succinct overview of the major achievements of LPMO research over the past decade. This journey through LPMOs landscape leads us to dive into the emerging biological functions of LPMOs and LPMO-like proteins. We notably highlight roles in fungal and oomycete plant pathogenesis (e.g., potato late blight), but also in mutualistic/commensalism symbiosis (e.g., ectomycorrhizae). We further present the potential importance of LPMOs in other microbial pathogenesis including diseases caused by bacteria (e.g., pneumonia), fungi (e.g., human meningitis), oomycetes and viruses (e.g., entomopox), as well as in (micro)organisms development (including several plant pests). Our assessment of the literature leads to the formulation of outstanding questions, promising for the coming years exciting research and discoveries on these moonlighting proteins.
Human sialyltransferases primarily utilize CMP‐Sias, especially transferring Neu5Ac from CMP‐Neu5Ac to various acceptors. Advances in chemical biology have led to the synthesis of novel CMP‐Sia donors suitable for bioorthogonal reactions in cell‐based assays. However, the compatibility of these donors with all human enzymes remains uncertain. We synthesized a non‐natural CMP‐Sia donor with an alkyne modification on the N ‐acyl group of Neu5Ac, which was effectively used by human ST6Gal I and ST3Gal I. A sensitive MicroPlate Sialyltransferase Assay (MPSA) was developed and expanded to a panel of 13 human STs acting on glycoproteins. All assayed enzymes tolerated CMP‐SiaNAl, allowing for the determination of kinetic parameters and turnover numbers. This study enhances the biochemical characterization of human sialyltransferases and opens new avenues for developing sialyltransferase inhibitors.